Investing.com - Stifel reiterated a Buy rating and $12.00 price target on Compass Therapeutics (NASDAQ:CMPX) shares, well above the current stock price of $5.10. The biotech company has delivered a ...
Space Compass and SWISSto12 have executed a procurement contract for the first GEO optical data relay satellite. This agreement represents a milestone toward the realisation of Space Compass’s optical ...
NASHVILLE, Tenn., March 19, 2026 (GLOBE NEWSWIRE) -- The Costigan Group at Compass rolls out a structured pre-acquisition screening framework for short-term rental investors, giving buyers a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results